| |
Latest 10 SEC filings (by transaction date) for SWTX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 3/24 | Apr 1/24 | Ashar Bhavesh | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -1,824 | $47.62 |
Feb 20/24 | Feb 16/24 | Pichl Daniel | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -15,000 | |
Feb 20/24 | Feb 16/24 | Pichl Daniel | Direct Ownership | Common Stock | S - Open market or private sale | -15,000 | $50.10 |
Feb 20/24 | Feb 16/24 | Pichl Daniel | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 15,000 | $27.64 |
Feb 5/24 | Feb 5/24 | Ashar Bhavesh | Direct Ownership | Common Stock | S - Open market or private sale | -4,834 | $49.32 |
Feb 5/24 | Feb 2/24 | Ashar Bhavesh | Direct Ownership | Common Stock | S - Open market or private sale | -88 | $46.37 |
Feb 5/24 | Feb 2/24 | Ashar Bhavesh | Direct Ownership | Common Stock | S - Open market or private sale | -378 | $46.00 |
Feb 5/24 | Feb 2/24 | Ashar Bhavesh | Direct Ownership | Common Stock | S - Open market or private sale | -1,667 | $44.31 |
Feb 5/24 | Feb 2/24 | Ashar Bhavesh | Direct Ownership | Common Stock | S - Open market or private sale | -1,089 | $43.75 |
Feb 5/24 | Feb 2/24 | Pichl Daniel | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -16,250 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for SWTX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 3/24 | Apr 1/24 | Ashar Bhavesh | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -1,824 | $47.62 |
Feb 20/24 | Feb 16/24 | Pichl Daniel | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -15,000 | |
Feb 20/24 | Feb 16/24 | Pichl Daniel | Direct Ownership | Common Stock | S - Open market or private sale | -15,000 | $50.10 |
Feb 20/24 | Feb 16/24 | Pichl Daniel | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 15,000 | $27.64 |
Feb 5/24 | Feb 5/24 | Ashar Bhavesh | Direct Ownership | Common Stock | S - Open market or private sale | -4,834 | $49.32 |
Feb 5/24 | Feb 2/24 | Ashar Bhavesh | Direct Ownership | Common Stock | S - Open market or private sale | -88 | $46.37 |
Feb 5/24 | Feb 2/24 | Ashar Bhavesh | Direct Ownership | Common Stock | S - Open market or private sale | -378 | $46.00 |
Feb 5/24 | Feb 2/24 | Ashar Bhavesh | Direct Ownership | Common Stock | S - Open market or private sale | -1,667 | $44.31 |
Feb 5/24 | Feb 2/24 | Ashar Bhavesh | Direct Ownership | Common Stock | S - Open market or private sale | -1,089 | $43.75 |
Feb 5/24 | Feb 2/24 | Pichl Daniel | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -16,250 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |